Narayan Prabhu 4
4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Apr 27, 2023
Insider Transaction Report
Form 4
Narayan Prabhu
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-25+170,000→ 170,000 totalExercise: $6.74Exp: 2033-04-24→ Common Stock, par value $0.0001 per share (170,000 underlying)
Footnotes (1)
- [F1]Represents an option award granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the "Reporting Person"), by the Issuer's compensation committee on April 25, 2023 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan.